Transgene, Association Francaise Contre Les Myopathies deal

The partners renewed until June 30, 2001 their agreement to develop gene therapy treatments for neuromuscular diseases, with a focus on Duchenne's Muscular Dystrophy (DMD). AFM will provide $14.7 mill...